compendium.ch
Buprenoratiopharm 35 Mikrogramm/Stunde Transdermales Pflaster - ratiopharm GmbH
compendium.ch
SWICA - Transtec®
Buprenorphin-ratiopharm® 70 Mikrogramm/h Transdermales Pflaster - ratiopharm GmbH
Buprenorphin Glenmark 7 Tage 10 Mikrogramm/Stunde transdermales Pflaster | Gelbe Liste
Buprenorphin-HEXAL® sublingual 0,4 mg Sublingualtabletten | Gelbe Liste
BUPRENORPHIN Glenmark 7T 5 μg/h tr.Pfl. 5mg/Pfl. - Beipackzettel | Apotheken Umschau
My story – Helping Marco
Bupre-HEXAL 70 Mikrogramm/Stunde transdermales Pflaster, 4 Tage | Gelbe Liste
DE102005016460A1 - Spriocyclic cyclohexane derivatives for the treatment of substance dependence - Google Patents
US9308202B2 - Transdermal therapeutic system for administering the active substance buprenorphine - Google Patents
EP1810670A1 - Combination of Polamidone and Naloxone for the treatment of drug addiction - Google Patents
EP1810714A1 - Use of a combination of heroin and naloxon for drug substitution - Google Patents
Bupre-HEXAL 7 Tage 5 Mikrogramm/Stunde transdermales Pflaster | Gelbe Liste
Buprenorphin – Wikipedia
Buprenorphin Glenmark 7 Tage 5 Mikrogramm/Stunde transdermales Pflaster | Gelbe Liste
DE102006019293A1 - Transdermal therapeutic system, useful for pain treatment, comprises a carrier layer, an adhesive layer comprising a pressure sensitive copolymer with a content of fentanyl and analogs and a removable protection
Buprenorphin Glenmark transdermales Pflaster (7 Tage) | Glenmark Arzneimittel GmbH
Buprenorphine (Butrans): Uses, Side Effects, Dosage & Reviews
DE102017112543A1 - Overtape for a transdermal delivery system - Google Patents
DE102005016460A1 - Spriocyclic cyclohexane derivatives for the treatment of substance dependence - Google Patents
BUPRENORPHIN Glenmark 7T 5 μg/h tr.Pfl. 5mg/Pfl. (12) | SaniPlus Direkt
Buprenorphin-neuraxpharm® Transdermale Pflaster - Neuraxpharm Deutsch
Bupre-HEXAL 52,5 Mikrogramm/Stunde transdermales Pflaster, 4 Tage | Gelbe Liste
Pharmakologie der Haut (HPH 1&2) Flashcards | Quizlet
